...
首页> 外文期刊>Oncology letters >Novel dynamin 2 mutations in adult T-cell acute lymphoblastic leukemia
【24h】

Novel dynamin 2 mutations in adult T-cell acute lymphoblastic leukemia

机译:成人T细胞急性淋巴细胞白血病中新的dynamin 2突变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Genetic mutations on signaling pathways are found in patients with T-cell acute lymphoblastic leukemia (T-ALL) and act as markers of high-risk leukemia. Mutations in dynamin 2 (DNM2) have been reported in T-ALL, particularly in early T-cell precursor-ALL. In the present study, DNM2 mutations were screened by sequencing DNM2 exons obtained by polymerase chain reaction amplification and gel purification in adult T-ALL patients. A total of 4 novel DNM2 mutations were identified in adult T-ALL patients, with a mutation rate of 9.5%, and the DNM2 mutations were found to co-exist with NOTCH1 and PHD finger protein 6, and were also associated with high-risk leukemia. A high rate of silent mutation was also found in the patients, but no significant association was found between the silent mutations and patients' clinical features. The present findings suggested the DNM2 mutations may be involved in the oncogenesis of T-ALL.
机译:在患有T细胞急性淋巴细胞性白血病(T-ALL)的患者中发现了信号通路的遗传突变,并作为高危白血病的标志物。在T-ALL,特别是在早期T细胞前体-ALL中,已报道了dynamin 2(DNM2)的突变。在本研究中,通过对成人T-ALL患者通过聚合酶链反应扩增和凝胶纯化获得的DNM2外显子进行测序,筛选了DNM2突变。在成人T-ALL患者中共鉴定出4种新的DNM2突变,突变率为9.5%,发现DNM2突变与NOTCH1和PHD手指蛋白6共存,并且还与高风险相关白血病。在患者中也发现了较高的沉默突变率,但是在沉默突变与患者的临床特征之间未发现显着关联。目前的发现表明,DNM2突变可能与T-ALL的肿瘤发生有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号